| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Depression | |||||
| Major Depression/Bipolar Disorder | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Bipolar Disorder | |||||
| Depressive Disorder | |||||
| Depressive Disorder, Major | |||||
| 3 | More general conditions related to this trial | ||||
| Affective Disorders, Psychotic | |||||
| Behavioral Symptoms | |||||
| Mental Disorders | |||||
| Mood Disorders | |||||
| 4 | Interventions listed in this trial | ||||
| Ketamine | |||||
| Riluzole | |||||
| FDG | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Anesthetics | |||||
| Anesthetics, Dissociative | |||||
| Anesthetics, General | |||||
| Anesthetics, Intravenous | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Excitatory Amino Acid Agents | |||||
| Excitatory Amino Acid Antagonists | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Mental Health (NIMH) | |||||
|
